Coronavirus News: Pepcid being used in new coronavirus drug trial with anti-malaria drug
NEW YORK (WABC) -- There's a potential new treatment for COVID-19, and it might not be what many people expect.
Researchers at Northwell Health have been enrolling patients into their study of famotidine.
That's the active ingredient in Pepcid, an over-the-counter medication commonly used to alleviate heartburn.
Since March 13, the drug has been being delivered through an IV in megadoses nine times greater than the typical over-the-counter dose to patients in the trial.
The drug is being given in combination with the antimalarial hydroxychloroquine.
Researchers say some data on safety will be available in a few weeks.
MORE CORONAVIRUS COVID-19 COVERAGE
COVID-19 Help, Information and Resources
UPDATES
Grieving the lost: Tri-State residents who have died
RELATED INFORMATION
Share your coronavirus story with Eyewitness News
Stimulus check scams and other coronavirus hoaxes
Coronavirus prevention: how clean are your hands?
Centers for Disease Control and Prevention on coronavirus
Total count of NYC COVID-19 cases based on patient address
